Bicycle Therapeutics plc

Bicycle Therapeutics plc - PE Ratioverified

BCYC

Price:

$4

Market Cap:

$277.58M

Bicycle Therapeutics plc, founded in 2009 and based in Cambridge, UK, is a clinical-stage biopharmaceutical company. Its core mission is to create innovative therapeutic classes for diseases currently lacking effective treatments. The company's leading investigational product, BT1718, is a Bicycle Toxin Conjugate (BTC) that is undergoing Phase I/IIa clinical trials. This candidate is engineered to target tumors specifically expressing Membrane Type 1 matrix metalloprotease. Other oncology assets in their pipeline include BT5528, also a BTC in Phase I/II studies, which targets EphA2, and BT8009, currently in Phase I/II clinical development, designed to target Nectin-4. Beyond cancer, Bicycle ...[Read more]

Industry

Biotechnology

IPO Date

2019-05-23

Stock Exchange

NASDAQ

Ticker

BCYC

The PE Ratio as of June 2026 (TTM) for Bicycle Therapeutics plc (BCYC) is -1.27

According to Bicycle Therapeutics plc’s latest financial reports and current stock price. The company's current PE Ratio is -1.27. This represents a change of -54.79% compared to the average of -2.81 of the last 4 quarters.

Bicycle Therapeutics plc (BCYC) Historical PE Ratio (quarterly & annually)

How has BCYC PE Ratio performed in the past?

The mean historical PE Ratio of Bicycle Therapeutics plc over the last ten years is -8.43. The current -1.27 PE Ratio has changed 1.41% with respect to the historical average. Over the past ten years (40 quarters), BCYC's PE Ratio was at its highest in in the March 2026 quarter at -1.33. The PE Ratio was at its lowest in in the December 2021 quarter at -24.15.

Quarterly (TTM)
Annual

Average

-8.43

Median

-7.03

Minimum

-22.80

Maximum

-2.24

Bicycle Therapeutics plc (BCYC) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Bicycle Therapeutics plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 237.84%

Maximum Annual PE Ratio = -2.24

Minimum Annual Increase = -65.83%

Minimum Annual PE Ratio = -22.80

Quarterly (TTM)
Annual
YearPE RatioChange
2025-2.24-53.43%
2024-4.8135.18%
2023-3.56-54.31%
2022-7.79-65.83%
2021-22.80237.84%
2020-6.7598.22%
2019-3.40-53.47%
2018-7.32-25.61%
2017-9.84-37.70%

Bicycle Therapeutics plc (BCYC) Average PE Ratio

How has BCYC PE Ratio performed in the past?

The current PE Ratio of Bicycle Therapeutics plc (BCYC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-3.54

5-year avg

-8.24

10-year avg

-8.43

Bicycle Therapeutics plc (BCYC) PE Ratio vs. Peers

How is BCYC’s PE Ratio compared to its peers?

Bicycle Therapeutics plc’s PE Ratio is greater than RAPT Therapeutics, Inc. (-14.81), less than Neumora Therapeutics, Inc. Common Stock (-1.14), less than Omeros Corporation (7.91), greater than Lexicon Pharmaceuticals, Inc. (-28.15), greater than KalVista Pharmaceuticals, Inc. (-8.36), less than ADC Therapeutics S.A. (-1.04), greater than Prothena Corporation plc (-3.18), greater than 4D Molecular Therapeutics, Inc. (-3.63), greater than Fulcrum Therapeutics, Inc. (-3.22), greater than Compass Therapeutics, Inc. (-5.52),

Build a custom stock screener for Bicycle Therapeutics plc (BCYC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bicycle Therapeutics plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bicycle Therapeutics plc (BCYC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bicycle Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Bicycle Therapeutics plc's PE Ratio?

How is the PE Ratio calculated for Bicycle Therapeutics plc (BCYC)?

What is the highest PE Ratio for Bicycle Therapeutics plc (BCYC)?

What is the 3-year average PE Ratio for Bicycle Therapeutics plc (BCYC)?

What is the 5-year average PE Ratio for Bicycle Therapeutics plc (BCYC)?

How does the current PE Ratio for Bicycle Therapeutics plc (BCYC) compare to its historical average?